| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 151.57B | 150.74B | 136.16B | 129.36B | 127.82B | 117.25B |
| Gross Profit | 35.08B | 34.74B | 29.75B | 25.71B | 28.68B | 26.66B |
| EBITDA | 16.11B | 15.81B | 13.23B | 13.00B | 16.56B | 15.61B |
| Net Income | 6.56B | 6.53B | 4.53B | 4.85B | 7.69B | 7.28B |
Balance Sheet | ||||||
| Total Assets | 151.99B | 153.93B | 141.68B | 128.44B | 127.37B | 117.39B |
| Cash, Cash Equivalents and Short-Term Investments | 20.43B | 22.48B | 32.11B | 30.62B | 28.15B | 24.28B |
| Total Debt | 4.44B | 6.25B | 3.13B | 3.12B | 2.53B | 3.26B |
| Total Liabilities | 52.29B | 53.23B | 48.04B | 39.16B | 42.15B | 39.45B |
| Stockholders Equity | 91.29B | 92.00B | 85.96B | 82.45B | 79.34B | 73.06B |
Cash Flow | ||||||
| Free Cash Flow | -10.61B | -11.14B | 3.15B | 3.23B | 6.10B | 2.17B |
| Operating Cash Flow | 4.55B | 6.59B | 10.08B | 8.37B | 11.40B | 11.89B |
| Investing Cash Flow | -15.02B | -17.46B | -6.10B | -3.97B | -5.18B | -9.89B |
| Financing Cash Flow | 1.02B | 269.00M | -3.51B | -2.44B | -2.77B | -806.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
77 Outperform | ¥96.87B | 7.99 | 7.53% | 3.01% | 5.44% | 45.99% | |
76 Outperform | ¥13.61B | 8.51 | ― | 1.20% | 6.42% | -6.32% | |
74 Outperform | ¥75.67B | 12.05 | ― | 6.64% | 2.85% | -9.13% | |
73 Outperform | ¥57.13B | 5.78 | ― | 3.31% | 0.83% | -9.16% | |
70 Outperform | ¥140.93B | 4.25 | 10.46% | 2.35% | 4.56% | 49.23% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
55 Neutral | ¥19.09B | 21.58 | ― | 4.39% | 5.06% | -15.22% |